Qisda Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Peter Chen
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | 12.3yrs |
| Eigendom CEO | 0.1% |
| Management gemiddelde ambtstermijn | 3.3yrs |
| Gemiddelde ambtstermijn bestuur | 4.5yrs |
Recente managementupdates
Recent updates
Analyse-update • Apr 02
2352: Steady Fair Value And Refined Assumptions Will Support Future Upside
Analysts have kept Qisda's fair value view broadly unchanged, with only very small tweaks to inputs like the discount rate and future P/E. These adjustments feed into a steady NT$36.73 price target that signals continued confidence in their existing valuation framework.Analyse-update • Mar 19
2352: Higher Profitability Assumptions And Steady Fair Value Will Support Future Upside
Analysts kept their NT$36.73 price target for Qisda unchanged, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E that effectively offset one another in their updated model. Valuation Changes Fair Value: NT$36.73 is unchanged in the updated model, indicating no revision to the overall equity value per share.Analyse-update • Mar 04
2352: Stable Assumptions And Slightly Higher P E Will Support A Higher Share Price
Analysts have made a small upward adjustment to their Qisda price target to reflect updated assumptions around the discount rate and future P/E. They have kept their fair value estimate broadly unchanged at about NT$36.73 per share.Analyse-update • Feb 18
2352: Stable Assumptions And Lower Discount Rate Will Support A Higher Share Price
Analysts have modestly adjusted their price target on Qisda to NT$36.73, reflecting fine tuning of assumptions such as a slightly lower discount rate, stable revenue growth and profit margin expectations, and a marginally revised future P/E multiple. Valuation Changes Fair Value: NT$36.73 is unchanged, indicating the updated inputs leave the core valuation estimate essentially the same.
Nieuwe analyse • Feb 06
AI Hardware Delays And Medical Regulatory Risks Will Eventually Support A Gradual Turnaround
Catalysts About Qisda Qisda is a diversified electronics and solutions group with businesses spanning information technology hardware, medical equipment and services, smart business solutions and networking and communications. What are the underlying business or industry changes driving this perspective?Analyse-update • Feb 03
2352: Steady Assumptions And Higher Required Return Will Support A Higher Share Price
Analysts have kept their price target for Qisda steady at US$36.73. Modest tweaks to inputs such as the discount rate and assumed future P/E suggest only fine tuning rather than a shift in their underlying outlook.Analyse-update • Jan 19
2352: Stable Long Term Assumptions Will Support A Higher Future Share Price
Analysts have kept their Qisda fair value estimate steady at about $36.73 per share, with only very small model updates to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. Valuation Changes Fair Value: The intrinsic value estimate is unchanged at about NT$36.73 per share.Analyse-update • Jan 05
2352: Stable Assumptions And Earnings Outlook Will Support Stronger Share Price
Analysts have kept their price target for Qisda broadly in line with prior estimates. The changes reflect only very small model tweaks around discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major change in their view of the stock.Analyse-update • Dec 14
2352: Stable Earnings Outlook Should Support Stronger Future Share Price Performance
Analysts have raised their price target on Qisda modestly to reflect slightly lower discount rates and a marginally improved long term earnings outlook, while keeping fair value estimates effectively unchanged at around $36.73 per share. Valuation Changes Fair Value Estimate: Unchanged at approximately NT$36.73 per share, indicating no material revision in the intrinsic value assessment.Analyse-update • Nov 29
2352: Lower Profit Margins Will Give Way To Future Share Price Upside
Analysts have slightly revised their price target for Qisda downward from $37.80 to $36.73. This change is attributed to moderate adjustments to profit margin expectations and future earnings estimates.Analyse-update • Nov 15
2352: Earnings Strength and Higher Margins Will Support Upcoming Share Upside
Narrative Update: Qisda Analyst Price Target Revised Analysts have raised their price target for Qisda, increasing it from $37.80 to $37.80. This revision is based on slightly higher expected revenue growth and profit margins, along with a modest uptick in the discount rate and projected future price-to-earnings ratio.Analyse-update • Nov 01
2352: Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda Analyst Price Target Updated Analysts have made a minor adjustment to Qisda’s price target, keeping it steady at $37.80. Recent analysis indicates only incremental changes to underlying valuation metrics.Analyse-update • Oct 17
Investments In AIoT And Medical Services Will Boost Future Profitability
Analysts have maintained their price target for Qisda at $37.80, citing stable financial indicators and minimal changes to key valuation metrics as supporting rationale for holding their previous outlook. Valuation Changes Fair Value: Remained unchanged at NT$37.80.Analyse-update • Oct 03
Investments In AIoT And Medical Services Will Boost Future Profitability
Analysts have raised their price target for Qisda from $31 to approximately $37.80, citing an adjusted fair value estimate. Other core financial projections remain consistent.Analyse-update • Sep 17
Investments In AIoT And Medical Services Will Boost Future Profitability
The notable downward revision in Qisda’s consensus analyst price target is primarily driven by a significant decline in net profit margin and a slight decrease in future P/E, lowering fair value from NT$35.75 to NT$31.00. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly fallen from NT$35.75 to NT$31.00.Analyse-update • Sep 02
Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda’s higher consensus price target reflects a sharp increase in its expected future P/E ratio, signaling improved earnings growth prospects or investor confidence, raising fair value from NT$28.50 to NT$35.75. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly risen from NT$28.50 to NT$35.75.
Nieuwe analyse • Feb 21
Investments In AIoT And Medical Services Will Boost Future Profitability
Qisda’s focus on AIoT and AI technologies may increase revenue streams and improve gross margins through innovation in smart automation solutions.Analyse-artikel • Mar 12
Qisda's (TWSE:2352) Weak Earnings May Only Reveal A Part Of The Whole Picture
The market wasn't impressed with the soft earnings from Qisda Corporation ( TWSE:2352 ) recently. We did some further...Analyse-artikel • Mar 09
Qisda Corporation Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next
Qisda Corporation ( TWSE:2352 ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...Analyse-artikel • Feb 29
Qisda (TWSE:2352) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analyse-artikel • Mar 15
Is Qisda Corporation (TPE:2352) A Smart Pick For Income Investors?
Dividend paying stocks like Qisda Corporation ( TPE:2352 ) tend to be popular with investors, and for good reason...Analyse-artikel • Feb 26
Qisda Corporation's (TPE:2352) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Qisda's (TPE:2352) stock is up by a considerable 32% over the past three months. However, we decided to pay attention...Analyse-artikel • Feb 08
These 4 Measures Indicate That Qisda (TPE:2352) Is Using Debt Reasonably Well
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analyse-artikel • Jan 24
Should You Use Qisda's (TPE:2352) Statutory Earnings To Analyse It?
It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. That...Analyse-artikel • Jan 09
Qisda (TPE:2352) Has Gifted Shareholders With A Fantastic 275% Total Return On Their Investment
When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...CEO
Peter Chen (64 yo)
12.3yrs
Tenure
Mr. Chi-Hong Chen, also known as Peter, is Non Executive Chairperson of BenQ BM Holding Cayman Corporation from March 22, 2024 and serves as its Director since May 27, 2013. Mr. Chen joined the BenQ BM Hol...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Chairman | no data | geen gegevens | 0.13% NT$ 49.2m | |
| President | no data | geen gegevens | geen gegevens | |
| VP, CFO & Accounting Officer | no data | geen gegevens | 0.038% NT$ 14.8m | |
| VP and Chief HR | 4.3yrs | geen gegevens | 0.015% NT$ 5.8m | |
| President of the Network Communication Business Unit | 2.3yrs | geen gegevens | geen gegevens | |
| Vice Chairman & Director | no data | geen gegevens | 0.045% NT$ 17.6m | |
| VP & President of the Medical Devices Products Group | no data | geen gegevens | geen gegevens | |
| GM of Manufacturing Operations & MD of Qisda China | 2.3yrs | geen gegevens | geen gegevens | |
| CIO | no data | geen gegevens | geen gegevens | |
| Chief Information Security Officer | 6.2yrs | geen gegevens | geen gegevens | |
| VP & GM of Information Technology Business Group | no data | geen gegevens | geen gegevens | |
| VP & GM of Commercial & Industrial Business Group | no data | geen gegevens | 0.0031% NT$ 1.2m |
3.3yrs
Gemiddelde duur
Ervaren management: Het managementteam van 2352 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.3 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Chairman | 12.3yrs | geen gegevens | 0.13% NT$ 49.2m | |
| Vice Chairman & Director | 8.9yrs | geen gegevens | 0.045% NT$ 17.6m | |
| Director | 3yrs | geen gegevens | 0.000030% NT$ 11.8k | |
| Independent Director | 5.9yrs | geen gegevens | geen gegevens | |
| Independent Director | 5.9yrs | geen gegevens | geen gegevens | |
| Independent Director | 3yrs | geen gegevens | geen gegevens | |
| Independent Director | 3yrs | geen gegevens | geen gegevens | |
| Independent Director | 3yrs | geen gegevens | geen gegevens |
4.5yrs
Gemiddelde duur
64yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 2352 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.5 jaar).
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/09 08:35 |
| Aandelenkoers aan het einde van de dag | 2026/05/08 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Qisda Corporation wordt gevolgd door 6 analisten. 1 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Nicholas Teo | CLSA |
| Joey Cheng | Goldman Sachs |
| null null | KGI Securities Co. Ltd. |